Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

44.1K
Overview
44.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Proxy immunization enabling yellow fever vaccination after thymectomy.

NPJ vaccines·2026
Same author

Characterisation of immune responses targeting highly pathogenic avian influenza A(H5) viruses in health-care workers in the Netherlands: an observational, cross-sectional analysis.

The Lancet. Microbe·2026
Same author

Humoral and cellular immune response after COVID-19 vaccination in patients with sickle cell disease on hydroxyurea.

Blood advances·2026
Same author

Incidence of Community-acquired Pneumonia and Herpes Zoster in People With HIV Based on CD4 Count and Age in the Current Antiretroviral Therapy Era: A Longitudinal Cohort Study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025
Same author

T-cell responses to SARS-CoV-2 vaccinations in adults with Down syndrome - a prospective cohort study.

Human vaccines & immunotherapeutics·2025
Same author

Insights to a Cure: Unique Controller Phenotypes in the Rotterdam HIV-2 Cohort.

Open forum infectious diseases·2025

Related Experiment Video

Updated: Jun 6, 2025

Author Spotlight: Development of a Smartphone-Enhanced Paper-Based Device for Rapid Dengue NS1 Detection
06:00

Author Spotlight: Development of a Smartphone-Enhanced Paper-Based Device for Rapid Dengue NS1 Detection

Published on: January 26, 2024

1.2K

[Dengue vaccination: when and for whom?]

Christine A Timmer1,2, Zsofia Igloi3, Maarten J Sarink4

  • 1Medisch Centrum Leeuwarden, afd. Interne Geneeskunde, Leeuwarden.

Nederlands Tijdschrift Voor Geneeskunde
|November 28, 2024
PubMed
Summary

Dengue fever, a mosquito-borne illness, is spreading globally. Vaccination is crucial for preventing severe dengue hemorrhagic fever, especially with rising imported cases and potential reinfections.

More Related Videos

Protocol for Dengue Infections in Mosquitoes A. aegypti and Infection Phenotype Determination
15:25

Protocol for Dengue Infections in Mosquitoes A. aegypti and Infection Phenotype Determination

Published on: July 4, 2007

18.4K
A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease
04:23

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

Published on: April 28, 2019

6.5K

Related Experiment Videos

Last Updated: Jun 6, 2025

Author Spotlight: Development of a Smartphone-Enhanced Paper-Based Device for Rapid Dengue NS1 Detection
06:00

Author Spotlight: Development of a Smartphone-Enhanced Paper-Based Device for Rapid Dengue NS1 Detection

Published on: January 26, 2024

1.2K
Protocol for Dengue Infections in Mosquitoes A. aegypti and Infection Phenotype Determination
15:25

Protocol for Dengue Infections in Mosquitoes A. aegypti and Infection Phenotype Determination

Published on: July 4, 2007

18.4K
A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease
04:23

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

Published on: April 28, 2019

6.5K

Area of Science:

  • Tropical Medicine
  • Infectious Diseases
  • Epidemiology

Context:

  • Dengue fever is a prevalent mosquito-borne tropical disease with expanding geographical reach.
  • Increasing autochthonous dengue cases are reported in Southern Europe, while the Netherlands primarily sees imported cases.
  • Mosquito vectors are spreading to new regions, including Europe, posing a growing public health concern.

Purpose:

  • To present a case of dengue hemorrhagic fever following dengue virus reinfection.
  • To highlight the potential for severe dengue outcomes, including dengue hemorrhagic fever and dengue shock syndrome.
  • To discuss the role and availability of dengue vaccination in prevention strategies.

Summary:

  • A patient developed severe dengue hemorrhagic fever after being reinfected with the dengue virus.
  • This case underscores the risk of severe disease progression upon secondary dengue infection.
  • Early diagnosis and supportive care are vital, but prevention through vaccination is paramount.

Impact:

  • Emphasizes the need for increased vigilance regarding dengue virus transmission in non-endemic regions.
  • Highlights dengue vaccination as a key preventive measure against severe disease manifestations.
  • Informs public health strategies for managing the global spread of dengue and its associated risks.